Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02506686 |
Recruitment Status :
Completed
First Posted : July 23, 2015
Last Update Posted : July 23, 2015
|
Sponsor:
Huashan Hospital
Information provided by (Responsible Party):
Jufang Wu, Huashan Hospital
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet
publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending
Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during
QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review
assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific
validity or relevance of the submitted information.
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 2009 |
Actual Study Completion Date : | December 2009 |
Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
---|---|---|
1 |
April 17, 2016 | May 23, 2016 |
2 |
May 25, 2016 | July 5, 2016 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):